NASDAQ:NARI Inari Medical (NARI) Stock Price, News & Analysis $51.39 0.00 (0.00%) (As of 10:18 AM ET) Add Compare Share Share Today's Range$51.17▼$51.7850-Day Range$37.34▼$51.3952-Week Range$36.73▼$71.85Volume71,635 shsAverage Volume1.05 million shsMarket Capitalization$2.99 billionP/E RatioN/ADividend YieldN/APrice Target$65.71 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Inari Medical alerts: Email Address Inari Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.71 Rating ScoreUpside/Downside27.9% Upside$65.71 Price TargetShort InterestBearish9.56% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.04Based on 28 Articles This WeekInsider TradingSelling Shares$8.67 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.41) to $0.20 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.78 out of 5 starsMedical Sector587th out of 879 stocksSurgical & Medical Instruments Industry70th out of 95 stocks 3.4 Analyst's Opinion Consensus RatingInari Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageInari Medical has only been the subject of 4 research reports in the past 90 days.Read more about Inari Medical's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.56% of the float of Inari Medical has been sold short.Short Interest Ratio / Days to CoverInari Medical has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Inari Medical has recently increased by 5.80%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldInari Medical does not currently pay a dividend.Dividend GrowthInari Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NARI. Previous Next 1.7 News and Social Media Coverage News SentimentInari Medical has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 28 news articles for Inari Medical this week, compared to 8 articles on an average week.MarketBeat FollowsOnly 1 people have added Inari Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inari Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,667,431.00 in company stock.Percentage Held by Insiders10.60% of the stock of Inari Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions90.98% of the stock of Inari Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inari Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Inari Medical are expected to grow in the coming year, from ($0.41) to $0.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inari Medical is -125.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inari Medical is -125.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInari Medical has a P/B Ratio of 6.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Inari Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About Inari Medical Stock (NASDAQ:NARI)Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Read More NARI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NARI Stock News HeadlinesJuly 4, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) CEO Sells $150,240.00 in StockJuly 4, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) Director William Hoffman Sells 20,000 SharesJuly 8, 2024 | Insiders Exposed (Ad)Has Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.June 25, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) Director Rebecca Chambers Sells 260 SharesJune 15, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) CFO Sells $238,000.00 in StockJuly 8 at 5:45 AM | prnewswire.comShareholders that lost money on Inari Medical, Inc.(NARI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreJuly 8 at 5:45 AM | prnewswire.comShareholders that lost money on Inari Medical, Inc.(NARI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreJuly 7 at 7:41 PM | globenewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors With Losses in Excess of 100k to Secure Counsel Before Important Deadline in Securities Class Action – NARIJuly 8, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.July 7 at 10:35 AM | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari Medical, Inc. – NARIJuly 6 at 9:30 PM | prnewswire.comInari Medical, Inc. Sued for Securities Law Violations - Investors With Losses in Excess of $100K Should Contact The Rosen Law Firm Before July 12, 2024 to Discuss Your Rights - NARIJuly 6 at 4:09 PM | globenewswire.comInari Medical (NARI) Faces DOJ Probe and Investor Backlash Amid Kickback Allegations– Hagens BermanJuly 6 at 4:09 PM | globenewswire.comInari Medical (NARI) Faces DOJ Probe and Investor Backlash Amid Kickback Allegations– Hagens BermanJuly 5 at 6:00 PM | businesswire.comInari Medical, Inc. INVESTOR ALERT: Kirby McInerney LLP Alerts Inari Medical, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action LawsuitJuly 5 at 2:58 PM | seekingalpha.comInari Medical: A Touch Of Uncertainty And OvervaluationJuly 4, 2024 | americanbankingnews.comInari Medical, Inc. (NASDAQ:NARI) CEO Andrew Hykes Sells 3,000 Shares of StockJuly 3, 2024 | globenewswire.comROSEN, A LEADING NATIONAL FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARIJuly 3, 2024 | globenewswire.comDid Inari Medical (NARI) Buy Sales? Investor Lawsuit Claims Kickbacks Fueled Revenue – Hagens BermanSee More Headlines Receive NARI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today7/07/2024Next Earnings (Estimated)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NARI CUSIPN/A CIK1531048 Webwww.inarimedical.com Phone877-923-4747FaxN/AEmployees1,300Year FoundedN/APrice Target and Rating Average Stock Price Target$65.71 High Stock Price Target$84.00 Low Stock Price Target$50.00 Potential Upside/Downside+27.9%Consensus RatingModerate Buy Rating Score (0-4)2.71 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,640,000.00 Net Margins-4.54% Pretax Margin-2.04% Return on Equity-1.65% Return on Assets-1.23% Debt Debt-to-Equity RatioN/A Current Ratio2.71 Quick Ratio2.19 Sales & Book Value Annual Sales$493.63 million Price / Sales6.05 Cash Flow$0.09 per share Price / Cash Flow582.82 Book Value$8.07 per share Price / Book6.37Miscellaneous Outstanding Shares58,140,000Free Float51,975,000Market Cap$2.99 billion OptionableOptionable Beta1.01 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Andrew J. Hykes (Age 51)CEO, President & Director Comp: $1.54MMr. Mitchell C. Hill (Age 65)Chief Financial Officer Comp: $864.63kDr. Thomas M. Tu M.D. (Age 51)Chief Medical Officer Comp: $865.63kMr. Paul A. Koehn (Age 61)Senior Vice President of Operations Mr. Kevin StrangeSenior Vice President of Finance, Accounting, Strategy & Business DevelopmentMr. John Hsu C.F.A.Vice President of Investor RelationsMs. Angela AhmadGeneral Counsel & SecretaryMr. Eric KhairySenior Vice President of MarketingMr. Tim BennerSenior VP of Sales & Senior VP of U.S. SalesMs. Tara DunnSenior VP & GM of LimFlowMore ExecutivesKey CompetitorsCantel MedicalNYSE:CMDNuVasiveNASDAQ:NUVATeleflexNYSE:TFXGlobus MedicalNYSE:GMEDSolventumNYSE:SOLVView All CompetitorsInsiders & InstitutionsGAMMA Investing LLCBought 438 shares on 7/2/2024Ownership: 0.001%William HoffmanSold 20,000 sharesTotal: $1.00 M ($50.15/share)Andrew HykesSold 3,000 sharesTotal: $150,240.00 ($50.08/share)Rebecca ChambersSold 260 sharesTotal: $11,957.40 ($45.99/share)Mitch C HillSold 5,000 sharesTotal: $238,000.00 ($47.60/share)View All Insider TransactionsView All Institutional Transactions NARI Stock Analysis - Frequently Asked Questions How have NARI shares performed this year? Inari Medical's stock was trading at $64.92 at the beginning of 2024. Since then, NARI shares have decreased by 20.8% and is now trading at $51.39. View the best growth stocks for 2024 here. How were Inari Medical's earnings last quarter? Inari Medical, Inc. (NASDAQ:NARI) issued its earnings results on Tuesday, April, 30th. The company reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by $0.15. The firm had revenue of $143.19 million for the quarter, compared to the consensus estimate of $138.32 million. Inari Medical had a negative trailing twelve-month return on equity of 1.65% and a negative net margin of 4.54%. When did Inari Medical IPO? Inari Medical (NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers. Who are Inari Medical's major shareholders? Top institutional investors of Inari Medical include GAMMA Investing LLC. Insiders that own company stock include Donald B Milder, William Hoffman, Andrew Hykes, Thomas Tu and Mitch C Hill. View institutional ownership trends. How do I buy shares of Inari Medical? Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Inari Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO) and Johnson & Johnson (JNJ). This page (NASDAQ:NARI) was last updated on 7/8/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored50-year Wall Street Legend: “Prepare for a cash avalanche”The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the star...Chaikin Analytics | SponsoredObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happ...Porter & Company | SponsoredTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house...Wealthpin Pro | SponsoredNew Government Policy to Wipe Out Seniors WealthDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inari Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
